Brief: Relay Medical Says Co, Glow Lifetech Report Success In Phase II Clinical Results For Covid-19 Treatment
14/01/2021 21:43
Jan 14 (Reuters) - Relay Medical Corp RELA.CD :
* RELAY MEDICAL AND GLOW LIFETECH REPORT ON SUCCESSFUL PHASE
II
CLINICAL RESULTS FOR COVID-19 TREATMENT CANDIDATE BASED ON ITS
MYCELL TECHNOLOGY™
* RELAY MEDICAL - PHASE II TRIAL SHOW MYCELL TECHNOLOGY
ARTEMIC
FORMULATION, SUCCESSFULLY MET PRIMARY AND SECONDARY ENDPOINTS
FOR SAFETY AND EFFICACY
Source text for Eikon: ID:nGNXc0tQhQ
Further company coverage: RELA.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NorthPalm Capital
See all newsBrief: Scryb Announces Partnership Between Cybeats And Veracode
Brief: Relay Medical Says Co, Glow Lifetech Report Success In Phase II Clinical Results For Covid-19 Treatment
Brief: Relay Medical & Fio Reports Over $500,000 CAD In Contracts For Fionet Mobile Covid-19 Testing & Tracking Platform
Brief: Relay Medical Subsidiary Signs Binding Loi For Rights To Covid-19 Rapid Antigen And Antibody Tests
Brief: Relay Medical And Fio Corporation Announces High-Volume Manufacturing Partner For Its Covid-19 Mobile Testing Device